MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    The Cognitive Features of Idiopathic Cervical Dystonia: a cross-sectional study

    H. Oliveira, S. Camargos (Belo Horzionte, Brazil)

    Objective: To investigate the cognitive performance and the neuropsychiatric profile of patients with idiopathic adult-onset cervical dystonia (CD), to determine the occurrence of neuropsychiatric abnormalities…
  • MDS Virtual Congress 2021

    Cluster headache associated with secondary unilateral blepharospasm : A Case Report

    P. Dugani, A. Mehta, P. R, M. Javali, P. Acharya, R. Srinivasa (Bengaluru, India)

    Objective: We describe a case of a 31 year old lady with cluster headache associated with secondary unilateral spasm of left eyelid resulting in closure…
  • MDS Virtual Congress 2021

    Late-onset Familial Segmental Dystonia with Novel GNAL Mutation

    B. Barton, J. Karl, L. Verhagen, M. Rosenbaum (Chicago, USA)

    Objective: Report a unique onset of dystonia in family affected by tremor and segmental dystonia Background: Background: A 66-year-old woman of Norweigan descent presented with…
  • MDS Virtual Congress 2021

    GPi-DBS for KMT2B-associated dystonia: systematic review and meta-analysis

    A. Saini (New Deelhi, India)

    Objective: To determine the efficacy of pallidal stimulation and GPi-DBS in KMT2B-associated dystonia. Background: Early evidence suggests good response to pallidal stimulation in KMT2B dystonia,…
  • MDS Virtual Congress 2021

    Evaluation of abnormal cerebellar iron distribution in idiopathic cervical dystonia using quantitative susceptibility mapping

    HX. Li, M. Zhang, YH. Wu, YF. Li, HJ. Wei, YW. Wu (Shanghai, China)

    Objective: This study aimed to investigate abnormal cerebellar iron distribution in patients with idiopathic CD using quantitative susceptibility mapping (QSM). Background: Idiopathic CD is a…
  • MDS Virtual Congress 2021

    Overview of the population of patients with advanced Parkinson’s disease (aPD) initiating therapy with levodopa-carbidopa intestinal gel (LCIG): POMPE-PARK study on French health insurance data (2013-2017)

    JP. Azulay, D. Grabli, S. Benard, N. Kabore, MS. Behier (Marseille, France)

    Objective: To quantify the number of French aPD patients initiating continuous delivery of LCIG from 2013 to 2017 and to describe their demographic, clinical and…
  • MDS Virtual Congress 2021

    Is past use of statins associated with lower incidence of Parkinson’s disease?

    TTH. Nguyen, A. Fournier, F. Artaud, E. Courtois, S. Escolano, P. Tubert-Bitter, MC. Boutron, G. Severi, E. Roze, I. Degaey, M. Canonico, I. Ahmed, A. Thiébaut, A. Elbaz (Villejuif, France)

    Objective: To examine the relation of past exposure to statins with Parkinson’s disease (PD) incidence. Background: Drug repurposing has recently emerged as a promising approach…
  • MDS Virtual Congress 2021

    Virtual Rehabilitation for Functional Movement Disorder

    H. Bhatt, L. Macgillivray, K. Marcelle, S. Lidstone (Toronto, Canada)

    Objective: We describe initial experiences using virtual rehabilitation in a specialized outpatient functional movement disorder (FMD) clinic. Background: Specialized rehabilitation programs have been shown to…
  • MDS Virtual Congress 2021

    HSP-SPG5A/CYP7B1: unusual clinical and genetic characteristics in an Indian family

    A. Orlacchio, M. Stasi, A. Stigliano, A. Meyyazhagan, T. Kawarai (Rome, Italy)

    Objective: To carry out a clinical and genetic study of a large Indian family emigrated in Italy with autosomal dominant hereditary spastic paraplegia (ADHSP). Background:…
  • MDS Virtual Congress 2021

    Proof-of-concept study testing bevantolol (SOM3355) as treatment of chorea in Huntington’s disease

    J. Gamez, M. Calopa, E. Muñoz, A. Ferré, O. Huertas, K. Mcallister, N. Reig, C. Scart-Grès, R. Insa, J. Kulisevsky (Barcelona, Spain)

    Objective: Proof-of-concept phase IIa study assessing bevantolol (SOM3355) efficacy and safety in reducing chorea in Huntington’s disease (HD). Background: Bevantolol hydrochloride, a β1‐adrenoceptor antagonist used…
  • « Previous Page
  • 1
  • …
  • 82
  • 83
  • 84
  • 85
  • 86
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley